NSF’s quality management maturity (QMM) assessment model
Posted: 10 December 2024 | | No comments yet
NSF’s quality management maturity (QMM) assessment model: future-proofing quality and supporting supply chain robustness
The NSF Quality Management Maturity (QMM) model has gained interest and credibility among some of the world’s largest and most dynamic pharmaceutical companies who want to ensure they have a positive quality culture, and that their quality functions are both effective and robust. Ultimately, it is also recognized that proactive action on maturing a QMS, supports a more robust supply chain and minimises supply disruption.
Related content from this organisation
- NSF’s quality management maturity (QMM) assessment model
- Regulatory Authority Inspection Comparison
- Whitepaper: What to expect from a regulatory inspection, an NSF expert guide
- Whitepaper: Optimise organisational culture & quality maturity
- Whitepaper: Drug shortages – why do they happen and how can we stop them?
Related topics
Biologics, Biopharmaceuticals, Drug Development, Good Manufacturing Practice (GMP), Manufacturing, Medical Devices, Outsourcing, QA/QC, Regulation & Legislation, Supply Chain, Sustainabaility, Vaccines
